HITRUST CSF Certified Logo

Biomedix Expands HITRUST CSF® Certification to Further Mitigate Risk in Third-Party Privacy, Security, and Compliance

HITRUST CSF Certification validates Biomedix is committed to meeting key regulations and protecting sensitive information. St Paul, MN, November 30th – Biomedix, a healthcare risk-assessment technology company with a portfolio of diagnostic devices and services that help guide patient care and eliminate gaps between the cost of care and compensation Read more…

Upcoming Webinar: Advancing Healthcare Equity By Addressing the Amputation Epidemic

A major consequence of racism in healthcare is the increased rate of adverse outcomes of chronic conditions in minority populations. Non-traumatic lower-extremity amputations are just one of the major adverse outcomes more likely to happen to patients in under-served communities. These amputations carry high risks of mortality, related complications, and Read more…

O'Brien ETF 128 being used on a patient to identify peripheral neuropathy

Biomedix to offer a free O’Brien ETF128 tuning fork with PADnet purchases for Diabetes Awareness Month

In honor of Diabetes Awareness Month this November, Biomedix is inviting all healthcare professionals to optimize care for their diabetic patients through the earlier identification of related chronic complications such as Peripheral Artery Disease (PAD), and now Peripheral Neuropathy through a new partnership with O’Brien Medical. To build on our Read more…

PADnet Xpress with laptop and screenshot

New published whitepaper establishes clinical accuracy of PADnet Xpress

Lower Extremity Review magazine published a whitepaper online highlighting a clinical study comparing the diagnostic results of PADnet Xpress with other established, gold-standard technologies used to perform physiologic studies to non-invasively detect peripheral artery disease (PAD). This whitepaper was authored by Sue Duval, PhD and Associate Professor of the University Read more…